First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors
首次人体剂量递增试验,旨在评估抗MAGEA1自体TCR转基因T细胞疗法在复发和难治性实体瘤中的临床安全性和有效性
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2023-008668
Wermke, Martin; Holderried, Tobias A W; Luke, Jason John; Morris, Van K; Alsdorf, Winfried H; Wetzko, Katrin; Andersson, Borje S; Wistuba, Ignacio I; Parra, Edwin R; Hossain, Mohammad B; Grund-Gröschke, Sandra; Aslan, Katrin; Satelli, Arun; Marisetty, Anantha; Satam, Swapna; Kalra, Mamta; Hukelmann, Jens; Kursunel, M Alper; Pozo, Karine; Acs, Andreas; Backert, Linus; Baumeister, Melissa; Bunk, Sebastian; Wagner, Claudia; Schoor, Oliver; Mohamed, Ali S; Mayer-Mokler, Andrea; Hilf, Norbert; Krishna, Delfi; Walter, Steffen; Tsimberidou, Apostolia M; Britten, Cedrik M